雌激素在妊娠初始阶段的病理生理作用:从围受孕期到早孕期结束的分子机制及对妊娠结局的临床意义
本叙述性综述由七名研究者在Pubmed和Embase检索文献,总结母体雌激素在自然妊娠和ART妊娠围受孕期及早孕期的作用。围受孕期雌二醇过低与自然妊娠未获妊娠相关,LH峰值时超生理浓度雌二醇与活产率降低及妊娠并发症风险升高相关;早孕期雌激素通过调控血管生成因子和免疫耐受微环境影响胎盘形成。
要点
- 围受孕期(受孕前1个月起)雌二醇过低与自然妊娠未获妊娠相关。
- LH峰值时超生理浓度雌二醇与活产率降低及妊娠并发症风险升高相关。
- 早孕期雌二醇过低可能与自然妊娠胎盘形成异常相关,雌二醇过高似乎恶化妊娠结局。
核心结论
- 现有证据支持围受孕期和早孕期雌二醇水平与妊娠结局相关,并进一步描绘出优化妊娠成功的最佳浓度范围。
- 雌激素如何与其他因素协同以维持对发育胎儿的局部耐受与对病原体免疫反应之间的精细平衡仍不清楚。
- 亟需进一步研究,包括识别雌激素反应的决定因素以及ART中个体化雌激素给药方案的生物标志物。
研究设计与样本
- 叙述性综述,数据由七名研究者在Pubmed和Embase数据库独立检索。
- 检索词包括「estrogens」或「estrogen level(s)」或「serum estradiol」或「estradiol/estrogen concentration」,与「early pregnancy」或「first trimester of pregnancy」或「preconceptional period」或「ART」或「In Vitro Fertilization (IVF)」或「Embryo Transfer」或「Frozen Embryo Transfer」或「oocyte donation」或「egg donation」或「miscarriage」或「pregnancy outcome」或「endometrium」组合。
主要发现
- 围受孕期(定义为受孕前1个月开始的关键时间窗)雌激素通过激活旁分泌/自分泌信号对子宫内膜容受性起关键作用。
- 自然妊娠中雌二醇水平过低与未获妊娠周期相关。
- LH峰值时超生理浓度雌二醇与活产率降低及妊娠并发症风险升高相关。
- 早孕期雌激素主要通过调控血管生成因子表达在胎盘形成中起重要作用,并通过重塑子宫自然杀伤细胞和辅助性T细胞功能参与免疫耐受子宫微环境的形成。
- 自然妊娠中雌二醇水平较低被认为触发胎盘形成异常,而雌二醇过量似乎恶化妊娠发育和结局。
临床怎么用
- 作者认为围受孕期和早孕期雌二醇水平与妊娠结局相关,并描绘出优化妊娠成功的最佳浓度范围。
- 作者指出亟需进一步研究,包括识别雌激素反应的决定因素以及ART中个体化雌激素给药方案的生物标志物。
局限性
- 雌激素如何与其他因素协同以维持对发育胎儿的局部耐受与对病原体免疫反应之间的精细平衡仍不清楚。
- 进一步研究高度必要,包括识别雌激素反应的决定因素以及ART中个体化雌激素给药方案的生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Estrogens regulate disparate female physiological processes, thus ensuring reproduction. Altered estrogen levels and signaling have been associated with increased risks of pregnancy failure and complications, including hypertensive disorders and low birthweight babies. However, the role of estrogens in the periconceptional period and early pregnancy is still understudied. OBJECTIVE AND RATIONALE: This review aims to summarize the current evidence on the role of maternal estrogens during the periconceptional period and the first trimester of pregnancies conceived naturally and following ART. Detailed molecular mechanisms and related clinical impacts are extensively described. SEARCH METHODS: Data for this narrative review were independently identified by seven researchers on Pubmed and Embase databases. The following keywords were selected: 'estrogens' OR 'estrogen level(s)' OR 'serum estradiol' OR 'estradiol/estrogen concentration', AND 'early pregnancy' OR 'first trimester of pregnancy' OR 'preconceptional period' OR 'ART' OR 'In Vitro Fertilization (IVF)' OR 'Embryo Transfer' OR 'Frozen Embryo Transfer' OR 'oocyte donation' OR 'egg donation' OR 'miscarriage' OR 'pregnancy outcome' OR 'endometrium'. OUTCOMES: During the periconceptional period (defined here as the critical time window starting 1 month before conception), estrogens play a crucial role in endometrial receptivity, through the activation of paracrine/autocrine signaling. A derailed estrogenic milieu within this period seems to be detrimental both in natural and ART-conceived pregnancies. Low estrogen levels are associated with non-conception cycles in natural pregnancies. On the other hand, excessive supraphysiologic estrogen concentrations at time of the LH peak correlate with lower live birth rates and higher risks of pregnancy complications. In early pregnancy, estrogen plays a massive role in placentation mainly by modulating angiogenic factor expression-and in the development of an immune-tolerant uterine micro-environment by remodeling the function of uterine natural killer and T-helper cells. Lower estrogen levels are thought to trigger abnormal placentation in naturally conceived pregnancies, whereas an estrogen excess seems to worsen pregnancy development and outcomes. WIDER IMPLICATIONS: Most current evidence available endorses a relation between periconceptional and first trimester estrogen levels and pregnancy outcomes, further depicting an optimal concentration range to optimize pregnancy success. However, how estrogens co-operate with other factors in order to maintain a fine balance between local tolerance towards the developing fetus and immune responses to pathogens remains elusive. Further studies are highly warranted, also aiming to identify the determinants of estrogen response and biomarkers for personalized estrogen administration regimens in ART.
引用
- Parisi F, Fenizia C, Introini A, et al. The pathophysiological role of estrogens in the initial stages of pregnancy: molecular mechanisms and clinical implications for pregnancy outcome from the periconceptional period to end of the first trimester. Hum Reprod Update. 2023. PMID: 37353909. doi:10.1093/humupd/dmad016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。